trial

Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression

NCTId NCT07315685
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 6 (estimated)
Sponsored by University Hospital, Rouen
Primary completion 2029-04-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
6 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2026-07-13
Primary completion
2029-04-08
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
neurostimulator

Sponsors

University Hospital, RouenLead Sponsor
Centre Hospitalier du RouvrayCollaborator
Groupe Hospitalier Pitie-SalpetriereCollaborator

Sites

2 total
Paris, FranceRouvray, France

Facts & assertions

4 sourced
Enrollment
6
Phase
NA
Primary Completion Date
2029-04-08
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
neurostimulator
drug
lead_sponsor
University Hospital, Rouen
company
collaborator
Centre Hospitalier du Rouvray
company
Groupe Hospitalier Pitie-Salpetriere
company
indication
Autism Spectrum Disorder
indication
Schizophrenia
indication
Schizophrenia Disorder
indication